Anti-Fibroblast activation protein, alpha antibody (Ab53066)

Prolyl endopeptidase FAP, 170 kDa melanoma membrane-bound gelatinase, Dipeptidyl peptidase FAP, Fibroblast activation protein alpha, Gelatine degradation protease FAP, Integral membrane serine protease, Post-proline cleaving enzyme, Serine integral membrane protease, Surface-expressed protease, FAPalpha, SIMP, Seprase, FAP

反应种属:Human
抗原名称:FAP
应用:WB, IHC

详细信息

免疫原Synthetic Peptide within Human FAP. The exact immunogen used to generate this antibody is proprietary information. Q12884
宿主/亚型Rabbit / IgG
抗体类型Polyclonal
产品形式Liquid
纯化方式Affinity purification Immunogen
储存缓冲液pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 1% BSA, 0.88% Sodium chloride
储存条件运输条件: Blue Ice 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Stable for 12 months at -20°C
无载体蛋白No

特异性

ab53066 detects endogenous levels of total Fibroblast activation protein, alpha. Please note the immunogen used to produce this product has 92% homology with Mouse DPPIV/CD26.

背景信息

Anti-Fibroblast activation protein, alpha (FAP) antibody (ab53066) is a rabbit polyclonal antibody and is validated for use in IHC-P, WB in human, mouse, rabbit samples. Anti-Fibroblast activation protein, alpha antibody (ab53066) has been cited over 134 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-Fibroblast activation protein, alpha antibody (ab53066) has high sensitivity and specificity. Anti-Fibroblast activation protein, alpha antibody (ab53066) has 13 independent reviews from customers. Anti-Fibroblast activation protein, alpha antibody (ab53066) specifically detects Fibroblast activation protein, alpha (UniProt ID: Q12884; Molecular weight: 88kDa) and is sold in 100 µg selling sizes. Fibroblast activation protein (FAP) is a type II transmembrane serine protease predominantly expressed in cancer-associated fibroblasts (CAFs) within the tumor microenvironment. Fibroblast activation protein (FAP) plays a crucial role in remodeling the extracellular matrix, promoting tumor growth, invasion, and metastasis. It is minimally expressed in normal tissues but significantly upregulated in various cancers, making it a potential biomarker for malignancy.

文献引用 (147)

Viscoelastic hydrogel primed CAR-macrophage for pulmonary fibrosis treatment.

粘弹性水凝胶预处理的CAR-巨噬细胞用于肺纤维化治疗。

Zhang Yan, Liu Zhiqiang, Kong Wenyu, Ao Yanxiao, Zhang Rui, Du Yanan

Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer.

识别程序性细胞死亡相关亚型揭示了结肠癌的免疫异质性和治疗差异。

Xia Peng, Qu Ying, Liu Quanzhong, Zhu Mengyan, Huang Bin, Wu Wei, Li Kening, Wu Lingxiang, Zhang Ruohan, Lv Yingli, Wang Qianghu

Dual Targeting of FAP-Directed Nanoparticles and FRα-Specific CAR-T Cells Induces Additive Anti-Tumor Effects in Triple-Negative Breast Cancer.

FAP靶向纳米颗粒和FRα特异性CAR-T细胞的双重靶向作用可对三阴性乳腺癌产生叠加的抗肿瘤效应。

Thongkleang Tanva, Thongchot Suyanee, Rodponthukwaji Kamonlatth, Luangwattananun Piriya, Tadpetch Kwanruthai, Yenchitsomanus Pa-Thai, Thuwajit Peti, Punnakitikashem Primana, Thuwajit Chanitra

Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer.

成纤维细胞活化蛋白α靶向纳米颗粒用于三阴性乳腺癌肿瘤微环境重塑和抗肿瘤治疗。

Lameirinhas Ana, Díez Paula, Hicke Francisco J, Ágreda-Roca Anna, Torres-Ruiz Sandra, Sánchez-Serrano Paloma, Tapia Marta, Lluch Ana, Bermejo Begoña, Cejalvo Juan Miguel, Martínez-Máñez Ramón, Eroles Pilar, Garrido-Cano Iris

From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?

从实验室到临床,再到手术刀,最终回归实验室:FAP在青少年血管纤维瘤中的表达。对FAPI-PET/CT成像和靶向治疗的潜在意义?

Pillong Lukas, Burgard Caroline, Rosar Florian, Demirkol Betül, Ebner Rafail, Linxweiler Maximilian, Bozzato Alessandro, Schick Bernhard, Wemmert Silke

A new (68)Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancer.

一种新型 (68)Ga 标记的二聚体 FAP 配体,用于推进癌症的靶向 PET 成像。

Li Feng, Kondam Chaitanya, Yang Zhen, Sangu Muthuraju, Chen Jiexiao, Holgate Rhonda, Zou Bingqing, Jin Jiankang, Nguyen James, Martin Philip, Zhang Shu, Yang Yanping, Mai Junhua, Zhou Lan, Martin Diego R, Liu Zhonglin

Combined antitumor activity of [(177)Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

[(177)Lu]Lu-FAPI-2286 和帕唑帕尼在肉瘤模型中的联合抗肿瘤活性:一项针对成纤维细胞活化蛋白的临床前治疗诊断研究。

Tseng Jin-Ren, Hsu Cheng-Lung, Hsieh Hsin-Hua, Ho Kung-Chu, Wu Chun-Yi, Lin Ko-Han, Chung Yi-Hsiu, Weng Chi-Chang

HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity.

HMGA2 和蛋白质亮氨酸甲基化驱动胰腺癌谱系可塑性

Dobersch Stephanie, Yamamoto Naomi, Schutter Aidan, Cavender Sarah M, Robertson Tess M, Kartha Nithya, Samraj Annie N, Doron Ben, Poole Lisa A, Wladyka Cynthia L, Zhang Amy, Jang Gun Ho, Mahalingam Aswanth H, Barreto Guillermo, Raghavan Srivatsan, Narla Goutham, Notta Faiyaz, Eisenman Robert N, Hsieh Andrew C, Kugel Sita

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

HMGA2表达可预测胰腺导管腺癌的亚型、生存期和治疗结果

Naomi Yamamoto ,Stephanie Dobersch ,Ian Loveless ,Annie N Samraj ,Gun Ho Jang ,Miki Haraguchi ,Liang-I Kang ,Marianna B Ruzinova ,Kiran R Vij ,Jacqueline L Mudd ,Thomas Walsh ,Rachael A Safyan ,Elena Gabriela Chiorean ,Sunil R Hingorani ,Nathan M Bolton ,Li Li ,Ryan C Fields ,David G DeNardo ,Faiyaz Notta ,Howard C Crawford ,Nina G Steele ,Sita Kugel

Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.

抗FAP CAR-NK细胞作为一种新型靶向疗法,用于治疗宫颈癌和癌相关成纤维细胞。

Polten Robert, Kutle Ivana, Stalp Jan Lennart, Hachenberg Jens, Seyda Ann-Kathrin, Neubert Lavinia, Kamp Jan C, von Kaisenberg Constantin, Schaudien Dirk, Hillemanns Peter, Klapdor Rüdiger, Morgan Michael, Schambach Axel
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15